Categories

Manufacturers

Suppliers

Online Shop for prescription drugs, health & beauty

Newsletter

RSS feed

No RSS feed added

REMIRTA table. 30 mg. 30 tablets View full size

REMIRTA table. 30 mg. 30 tablets

Remirta product is involved in some complex mechanisms of transmission of nerve impulses in the brain.
 

More details

16.00 €

1

REMIRTA table. 30 mg. 30 tablets

 REMIRTA table. 30 mg. 30 tablets, One drug tablet: Mirtazapine 30 mg

REMIRTA WHAT IS AND WHAT IT IS USED

Remirta product is involved in some complex mechanisms of transmission of nerve impulses in the brain.

 

Witness

 

Treatment of major depressive disorder.

 

 WHAT YOU SHOULD KNOW BEFORE TREATMENT WITH REMIRTA

 

Not be used in case of hypersensitivity to mirtazapine or any of the other veshtestva.Saobshtavat is rare reversible changes in blood counts including changes in the number of cells from different blood lines (agranulocytosis, leukopenia and granulocytopenia) during treatment with Remirta. They usually occur 4-6 weeks after the start of treatment and were fully reversible after termination. In order to detect agranulocytosis patients should be monitored for symptoms such as fever, sore throat, inflammation of the mouth (stomatitis) and other signs of infection. Upon detection of the symptoms, treatment should be discontinued and Blood counts. Patients should be informed about the importance of tezisimptomi. Careful dosing as well as regular and close monitoring is necessary in patients with:

  Epilepsy and organic brain syndrome - as with other antidepressants Remirta should be administered cautiously in patients with a history of seizures. Treatment was discontinued immediately if such rate or strengthening of existing seizures.

  Liver ~ renal failure treatment should be discontinued if jaundice occurs.

  Diseases of the heart - low blood pressure when chest pain (angina pectoris), and recent myocardial infarction should follow the specific warnings and take necessary medications. with Remirta.

  Diabetes - patients with diabetes, antidepressants may affect blood sugar control, insulin and / or oral hypoglycaemic agents should be consistent and that requires close monitoring of patients.

 

The product is used with caution in:

 

  difficulty in urinating as with increased prostate (prostatic hypertrophy);

  Acute narrow-angle glaucoma and increased intraocular pressure (could be slight changes occur in these conditions because of the low anticholinergic activity).

 

As with other antidepressants may experience worsening of symptoms in patients with schizophrenia or other psychotic disorders, paranoid thoughts can be intensified. Since untreated depressive phase of bipolar affective razstoystvo, the state can go into a manic phase. In the absence of improvement during the first few weeks of treatment, patients should be monitored. The desire for self-harm is inherent in depression and may continue until the expiry of the signs of the disease. According to the experience gained in the treatment of depression, any increased risk of self-harm is typical of the early stages of treatment. Although it does not get used antidepressants, discontinuation after prolonged intake of this product may cause nausea, headache and general nerazpolozhenie.Patsienti elderly are often more sensitive, especially to the adverse effects of antidepressants. Not reported more frequent adverse reactions Remirta in elderly patients than in other patient groups, although experience is limited.

 

Pregnancy

Tell your doctor if you are pregnant or breastfeeding! Product safety in pregnancy has not been established. It is not recommended to administer the product at this time. If treatment with Remirta, women of childbearing age should use adequate methods of contraception.

 

Breastfeeding

 

Tell your doctor if you are pregnant or breastfeeding! I do not recommend the use of the product during lactation.

 

Driving and operating machinery

 

In some patients, especially the elderly, Remirta can lead to transient drowsiness and impair attention and concentration. Patients should be warned of this possibility and to avoid driving or operating machinery.

 

Taking other medicines

 

Please tell your doctor or Pharmagen ^ evta if you are taking or have recently taken any other medicines, even if they are available without a prescription! Remirta may increase depressant effects of alcohol, and patients should be advised to avoid alcohol during treatment. Remirta should not be administered concomitantly with MAO - inhibitors and within two weeks after discontinuation of tyah.Produktat may increase drowsiness effects of benzodiazepines, so special attention is required for their joint use. Caution should be exercised when combining products with drugs to treat HIV, antifungals, erythromycin and nefazodone. Ednoremenno acceptance of ketoconazole increased blood levels and the effects of mirtazapine and phenytoin mu.Karbamazepin increased excretion of mirtazapine about twice that reduces its effect, and requires an increase in dose. The presence in the blood of Remirta increased by 50% when given with cimetidine. Remirta dose should be reduced when treatment with cimetidine and improved upon discontinuation of therapy with him. Remirta causes a mild and clinically insignificant increases in prothrombin time and bleeding time in patients treated with warfarin.

 

 HOW TO USE REMIRTA

 

Remirta Always take as prescribed by the doctor! If you are not sure how to take the medicine, ask your doctor or pharmacist The tablets are taken orally, if necessary with liquid without chewing. VazrastniLechenieto started with an initial dose of 15 mg daily. Usually the dose should be increased to obtain appropriate clinical response. The effective daily dose is usually between 15 and 45 mg.

 

Elderly

 

The recommended dose is as above. If you need a dose increase, it should be done under strict supervision of a physician.

 

Children

 

As safety and effectiveness in children have not been established, it does not apply in childhood.

 

Patients with renal or hepatic insufficiency

 

In such patients, the release of the product can be delayed, which should be considered in medicine. Remirta is suitable to be applied once daily, preferably before lyaganeVazmozhno is accepting it twice - morning and evening before lyagane.Lechenieto lasts for at least 4-6 months after the symptoms disappear. Then take the product be discontinued gradually. In appropriate doses of positive treatment response usually occurs within 2-4 weeks. An insufficient response, the dose may be increased to the maximum. In the absence of a reply in the next 2-4 weeks, treatment should be spre.Molya consult your doctor or pharmacist if you think Remirta effects are very strong or inadequate!

 

If you take too much of the drug:

 

If overdose Product symptoms are usually mild. Reported to suppress the central nervous system with disorientation and prolonged drowsiness, fast heart rate and a slight decrease or increase in blood pressure. Treatment includes gastric lavage and symptomatic and supportive resources vital functions.

 

If you forget to take Remirta In this case, do not take double doza.doza prescribed and continue treatment Auxiliaries veshtestvaProduktat contains lactose as an excipient. Inappropriate for people with lactase deficiency, galactosaemia or glucose / galactose malabsorption.

 

 POSSIBLE SIDE EFFECTS

 

Like all medicines, Remirta can cause side effects.

 

Although Remirta not cause addiction, sometimes after prolonged treatment interruption may be observed withdrawal symptoms. Most of these symptoms are mild and self-resolving. Most often they are reported nausea, anxiety and agitation. Even if these symptoms occur upon discontinuation of treatment, it should be understood that not of the underlying disease. So Remirta treatment should be discontinued gradually.

 

 STORAGE

 

Keep out of reach of children Store below 25 ° S.Da not use after the expiry date stated on the package!

 

Shelf life

 

3 (three) years

 Remirta Remirta
 
Film-coated Tablets Active substance: mirtazapine
 
 
 
staff
 
One drug tablet: Mirtazapine 30 mg
 
Excipients: lactose monohydrate, pregelatinised maize starch, colloidal anhydrous silica, croscarmellose sodium, magnesium stearate

Write your review

REMIRTA table. 30 mg. 30 tablets

REMIRTA table. 30 mg. 30 tablets

Remirta product is involved in some complex mechanisms of transmission of nerve impulses in the brain.
 

Write your review